Reprise Biomedical develops biological medical devices utilizing proprietary perfusion decellularization technology to create collagen scaffolds with preserved vasculature for enhanced cellular integration. Their products specifically address the challenges of deep and tunneling wounds, facilitating improved healing outcomes for patients.
Funding
$40.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic wounds, particularly deep and tunneling wounds, present a significant challenge in wound care management due to their complex anatomy and difficulty in achieving complete closure. Traditional wound care products often fail to adequately address the three-dimensional nature of these wounds, leading to prolonged healing times and increased risk of complications.
Solution
Reprise Biomedical offers a portfolio of biological medical devices, including Miro3D and MiroDry wound matrices, designed to address the challenges of complex wounds. Utilizing a proprietary perfusion decellularization technology, Reprise Biomedical creates collagen scaffolds with preserved vasculature, promoting rapid cellular integration and tissue regeneration. Their products provide a three-dimensional solution for deep and tunneling wounds, facilitating improved healing outcomes.
Target Audience
The primary target audience includes wound care specialists, surgeons, and healthcare providers managing patients with chronic, complex, and hard-to-heal wounds, particularly those with deep and tunneling characteristics.
Features
- Proprietary perfusion decellularization process that preserves the native vasculature within the collagen scaffold.
- Miro3D: A 2cm thick, three-dimensional collagen matrix specifically designed for deep, tunneling, and undermining wounds.
- MiroDry: A conformable wound matrix designed to adapt to any wound bed.
- Derived from porcine liver, providing a natural collagen source for enhanced biocompatibility.
- Products facilitate cellular integration and tissue regeneration within the wound site.